Preoperative Volume Substitution in Elective Surgery Patients

July 28, 2015 updated by: Dr. Thomas Kratz, Philipps University Marburg Medical Center

Preoperative Volume Substitution in Fasting Patients Undergoing Elective Surgery - Impact on Hemodynamic Stability During Anesthesia

Preoperative fasting can evoke a hypovolemia which may cause a hemodynamic instability during introduction of anesthesia.

The purpose of this study is to test the hypothesis that a defined preoperative volume substitution compared to standard procedure will result in a reduced incidence of hemodynamic instabilities during introduction of anesthesia in elective surgery patients.

Study Overview

Status

Completed

Intervention / Treatment

Detailed Description

The preoperative fasting period often lasts longer than 2 hours as recommended by various national and international anesthetic guidelines. Thus, hypovolemia is more often then anticipated. In awake patients this condition is often masked. Introduction of anesthesia often leads to an unmasking of hypovolemia with a consecutive hemodynamic instability.

Aim of the study is to test the hypothesis that a preoperative volume substitution (8 ml/kg RingerAcetate Solution in 15 min. prior to introduction of anesthesia) reduces possible hemodynamic instabilities during initiation of anesthesia.

Study Type

Interventional

Enrollment (Actual)

220

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Marburg, Germany, D-35033
        • University Hospital of Marburg, Department of Anesthesia

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (ADULT, OLDER_ADULT)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • Age ≥ 18 years
  • thyreoid, parathyroid or gallbladder surgery
  • general anesthesia

Exclusion Criteria:

  • coronary artery disease
  • congestive heart disease (≥ New York Heart Association (NYHA) 2)
  • insulin dependent diabetes mellitus
  • renal insufficiency (creatinine > 2,0 mg/dl)
  • cerebrovascular disease
  • severe hypertension (≥ antihypertensive drugs)

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: TREATMENT
  • Allocation: RANDOMIZED
  • Interventional Model: PARALLEL
  • Masking: SINGLE

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
SHAM_COMPARATOR: Control
preoperative none substitution of i.v. fluids.
ACTIVE_COMPARATOR: Volume
preoperative substitution of a defined amount of i.v. fluids (8 ml/kg RingerAcetate solution for 15 min prior to introduction of anesthesia).
Other Names:
  • RingerAcetate Solution
  • cristalloide

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
hemodynamic instability
Time Frame: at time of introduction of anesthesia

Hemodynamic instability during induction of anesthesia (0-10 min), defined as at least one of the following:

  • Systolic blood pressure < 80 mmHg or decrease of 20% in preexistent hypertension
  • Mean blood pressure < 50 mmHg or decrease of 20% or > 20 mmHg in preexistent hypertension
  • Bradycardia < 45/min or decrease of 20% in preexistent bradycardia < 60/min.
  • Tachycardia > 120/min
  • Cardiac index < 2.0 l/min/m²
at time of introduction of anesthesia

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Stroke volume index > 35 ml/m2
Time Frame: at time of anesthesia
at time of anesthesia
Stroke volume variation < 12 %
Time Frame: at time of anesthesia
at time of anesthesia
Enddiastolic area (EDA) > 10 cm2
Time Frame: at time of anesthesia
transthoracic echocardiographic parasternal short axis enddiastolic area
at time of anesthesia
inferior vana cava diameter (VCI) > 15 mm
Time Frame: at time of anesthesia
transthoracic echocardiographic inferior vena cava diameter
at time of anesthesia

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Thomas Kratz, MD, Department of Anesthesia and Intensive Care Medicine, University Hospital Marburg, Germany

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

March 1, 2013

Primary Completion (ACTUAL)

February 1, 2015

Study Completion (ACTUAL)

February 1, 2015

Study Registration Dates

First Submitted

March 13, 2013

First Submitted That Met QC Criteria

March 14, 2013

First Posted (ESTIMATE)

March 15, 2013

Study Record Updates

Last Update Posted (ESTIMATE)

July 29, 2015

Last Update Submitted That Met QC Criteria

July 28, 2015

Last Verified

July 1, 2015

More Information

Terms related to this study

Additional Relevant MeSH Terms

Other Study ID Numbers

  • UKGMVolume (OTHER: University Hospital of Marburg)

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Anesthesia

Clinical Trials on Control

3
Subscribe